Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03071094
Brief Title: A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)

First Submitted : February 10, 2017
First Submitted that Met QC Criteria : February 28, 2017
First Posted : March 6, 2017

Last Update Submitted that Met QC Criteria : March 11, 2020
Last Update Posted : March 12, 2020